Official site of LIXIANA® (edoxaban), a once-daily, oral direct factor Xa inhibitor for patients with nonvalvular atrial fibrillation (nonvalvular afib) or venous thromboembolism (VTE)
http://www.lixiana.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
1.4 seconds
DAIICHI SANKYO COMPANY, LIMITED
Toshiaki Tatematsu
1-2-58●●●●●●omachi
Shin●●●●a-ku , Tokyo, 140-8710
JP
View this contact
Thomson Reuters Professional KK
Brandy Thomson
5-2-2●●●●●asaka
Akasaka P●●●●●●●●●ding, 19F
Min●●●-ku , Tokyo, 107-6119
JP
View this contact
Thomson Reuters Professional KK
Brandy Thomson
5-2-2●●●●●asaka
Akasaka P●●●●●●●●●ding, 19F
Min●●●-ku , Tokyo, 107-6119
JP
View this contact
BUY YOUR DOMAIN
16
YEARS
3
MONTHS
19
DAYS
GMO INTERNET, INC. DBA ONAMAE.COM
WHOIS : whois.discount-domain.com
REFERRED : http://www.onamae.com
PAGES IN
THIS WEBSITE
20
SSL
EXTERNAL LINKS
9
SITE IP
40.118.104.64
LOAD TIME
1.399 sec
SCORE
6.2
LIXIANA® (edoxaban) | Official Site for Healthcare Professionals | lixiana.com Reviews
https://lixiana.com
Official site of LIXIANA® (edoxaban), a once-daily, oral direct factor Xa inhibitor for patients with nonvalvular atrial fibrillation (nonvalvular afib) or venous thromboembolism (VTE)
lixiana.com
ENGAGE AF-TIMI 48 Trial | LIXIANA® (edoxaban)
http://www.lixiana.com/clinical-trials/engage-af-timi-48
Summary of Product Characteristics. Switching Novel Oral Anticoagulants. Dosing in Special Populations and Situations. Efficacy and Safety Overview. Nonvalvular Atrial Fibrillation (NVAF). Results in NVAF Subgroups. Consistent Results in VTE Subgroups. ENGAGE AF-TIMI 48 Trial. Nonvalvular Atrial Fibrillation (NVAF) Patients. Venous Thromboembolism (VTE) Patients. Library of Presentation Materials. Explaining Disease and Risk. Switching Novel Oral Anticoagulants. Efficacy and Safety Overview. Key exclusio...
VTE Patient Subgroups | LIXIANA® (edoxaban)
http://www.lixiana.com/patient-types/vte-patients
Summary of Product Characteristics. Switching Novel Oral Anticoagulants. Dosing in Special Populations and Situations. Efficacy and Safety Overview. Nonvalvular Atrial Fibrillation (NVAF). Results in NVAF Subgroups. Consistent Results in VTE Subgroups. ENGAGE AF-TIMI 48 Trial. Nonvalvular Atrial Fibrillation (NVAF) Patients. Venous Thromboembolism (VTE) Patients. Library of Presentation Materials. Explaining Disease and Risk. Switching Novel Oral Anticoagulants. Efficacy and Safety Overview. Patients may...
Side Effects in VTE | LIXIANA® (edoxaban)
http://www.lixiana.com/efficacy-safety-side-effects/vte-treatment/vte-safety
Summary of Product Characteristics. Switching Novel Oral Anticoagulants. Dosing in Special Populations and Situations. Efficacy and Safety Overview. Nonvalvular Atrial Fibrillation (NVAF). Results in NVAF Subgroups. Consistent Results in VTE Subgroups. ENGAGE AF-TIMI 48 Trial. Nonvalvular Atrial Fibrillation (NVAF) Patients. Venous Thromboembolism (VTE) Patients. Library of Presentation Materials. Explaining Disease and Risk. Switching Novel Oral Anticoagulants. Efficacy and Safety Overview. In major sub...
Nonvalvular atrial fibrillation Patients | LIXIANA® (edoxaban)
http://www.lixiana.com/patient-types/nvaf-patients
Summary of Product Characteristics. Switching Novel Oral Anticoagulants. Dosing in Special Populations and Situations. Efficacy and Safety Overview. Nonvalvular Atrial Fibrillation (NVAF). Results in NVAF Subgroups. Consistent Results in VTE Subgroups. ENGAGE AF-TIMI 48 Trial. Nonvalvular Atrial Fibrillation (NVAF) Patients. Venous Thromboembolism (VTE) Patients. Library of Presentation Materials. Explaining Disease and Risk. Switching Novel Oral Anticoagulants. Efficacy and Safety Overview. Patient char...
Clinical Trials | LIXIANA® (edoxaban)
http://www.lixiana.com/clinical-trials
Summary of Product Characteristics. Switching Novel Oral Anticoagulants. Dosing in Special Populations and Situations. Efficacy and Safety Overview. Nonvalvular Atrial Fibrillation (NVAF). Results in NVAF Subgroups. Consistent Results in VTE Subgroups. ENGAGE AF-TIMI 48 Trial. Nonvalvular Atrial Fibrillation (NVAF) Patients. Venous Thromboembolism (VTE) Patients. Library of Presentation Materials. Explaining Disease and Risk. Switching Novel Oral Anticoagulants. Efficacy and Safety Overview. The primary ...
TOTAL PAGES IN THIS WEBSITE
20
Hailey & Aiden Medina || Official Site
http://www.haileyandaiden.com/index.php
Dick Clark's New Years Eve. Little Miss Muffit's Monster Sitting Service. What Would You Do? June 7, 2016. What Would You Do? June 17, 2016. What Would You Do? May 16, 2012. Hits since May 16, 2012. Hailey and Aiden Medina 2012-2014. To the Official Site. For Hailey and Aiden Medina. You may recognize Hailey from her sketches for College Humor. Or seen her in The Hollow Tree. While you may know Aiden from his work for companies such as Crayola. And Toys R Us. Aiden's images could pop up in brochures.
TOTAL LINKS TO THIS WEBSITE
9
Welcome
李春波设计师网-室内设计室内装修设计网站
Http:/ lixian2006.eju.cn/ 收藏该网址. 追求人性化空间,专注工装,高档住宅,别墅设计. 楼主，你设计的金黄色的灯背景不妨把金箔应用上去` `应该会更好 有兴趣的话，可以联系我` 希望有. 您好，我是森林之旅缅甸柚木地板公司，网址: http:/ www.forest-travel.net. 您好，我是武汉润鑫环保工程有限公司,专业治理 检测 甲醛、苯、TVOC与室内空气污染。 你好 我公司是专业贴金箔的 期待能与你合作 QQ839752138 电话 13971559905金箔.
lixian365.com
蠡县论坛-蠡县吧-蠡县在线 - Powered by Discuz!
来自蠡县在线客户端 www.lixian6.com. 中国的 小三 夜壶 与 春药 的迷局. 经过近3个月的前期筹备，蠡县品牌门户网站 蠡县在线 www.lixian6.com 正式上线与广大蠡县人们见面 [全文]. 一般都认为编辑每天做的事无非就是ctrl C ctrl V，整天面对办公室一台电脑，将其他网 [全文].
lixian8.com - This website is for sale! - lixian8 Resources and Information.
The owner of lixian8.com. Is offering it for sale for an asking price of 10000 USD! This webpage was generated by the domain owner using Sedo Domain Parking. Disclaimer: Sedo maintains no relationship with third party advertisers. Reference to any specific service or trade mark is not controlled by Sedo nor does it constitute or imply its association, endorsement or recommendation.
LIXIANA® (edoxaban) | Official Site for Healthcare Professionals
Summary of Product Characteristics. Switching Novel Oral Anticoagulants. Dosing in Special Populations and Situations. Efficacy and Safety Overview. Nonvalvular Atrial Fibrillation (NVAF). Results in NVAF Subgroups. Consistent Results in VTE Subgroups. ENGAGE AF-TIMI 48 Trial. Nonvalvular Atrial Fibrillation (NVAF) Patients. Venous Thromboembolism (VTE) Patients. Library of Presentation Materials. Explaining Disease and Risk. Switching Novel Oral Anticoagulants. Efficacy and Safety Overview. For patients...
AF・VTE edo-net
AF Opinion Leader インタビュー. リクシアナに関するよくある質問 Q&A をMedical Libraryからご覧いただけます。 心房細動 AF、静脈血栓塞栓症 VTE 深部静脈血栓症 DVTおよび肺血栓塞栓症 PTE の診断 治療にお役立ていただくためのアプリです。 AF Opinion Leader インタビュー. 日常診療におけるDOACの使い方や日本人を含む ENGAGE AF-TIMI 48試験 の成績などを専門医の先生方に動画で解説いただきました。 リクシアナの 疑問 ENGAGE AF-TIMI 48試験を中心に. AF Opinion Leader インタビュー.
华网新媒_微信营销推广行业领导品牌
Ningbo Lixianaite kitchen equipment co.,ltd
No products in the cart. GOOD QUALITY GOOD DESIGN. JUST FOR KITCHEN MACHINERY. WE HAVE MANY YEARS EXPERIENCE. WE SHIPPING WITHIN CONTRACT TIEM. WE CAN MAKE GOOD JOB. HOPE COOPERATE IN THE FURTURE.
LIXIANA
This website is intended as an information resource for patients who have been prescribed LIXIANA. I have nonvalvular atrial fibrillation (NVAF). I have venous thromboembolism (VTE). Deep vein thrombosis (DVT). Is an anticoagulant used to:. Prevent blood clots in the brain (stroke) and other blood vessels in your body. If you have a form of irregular heart rhythm called nonvalvular atrial fibrillation. From re-occurring in the blood vessels of your legs and/or lungs.
lixianapple.com，礼县苹果 ，网站建设中，域名可转让或合作！
顶级行业域名， 互联网 时代 最有价值无形资产. EMAIL 13904514090@qq.com QQ 188515918.
